WEBULL
News
TBRIF
0.041
NaN%
--
Weekly Report: what happened at TBRIF last week (0209-0213)?
Weekly Report · 6d ago
Therma Bright Portfolio Firm Inretio Hits Key Milestone in Stroke Device Trial
TipRanks · 02/10 13:29
Therma Bright Portfolio Update: Inretio Successfully Completes First-in-Human Cohort for PREVA(TM) Stroke Platform; Targets 2026 U.S. FDA Trial
Newsfile · 02/10 12:00
Weekly Report: what happened at TBRIF last week (0202-0206)?
Weekly Report · 02/09 09:34
Weekly Report: what happened at TBRIF last week (0126-0130)?
Weekly Report · 02/02 09:33
Weekly Report: what happened at TBRIF last week (0119-0123)?
Weekly Report · 01/26 09:33
Therma Bright Secures Follow-On Venowave Order as Compression Therapy Demand Rises
TipRanks · 01/20 13:40
Therma Bright Receives Follow-On Order for 200 Venowave Units from Gen-X Med
Reuters · 01/20 11:31
Therma Bright Sells an Additional 200-Units of Venowave(TM) to Strategic Distribution Partner Gen-X Med
Newsfile · 01/20 11:30
Weekly Report: what happened at TBRIF last week (0112-0116)?
Weekly Report · 01/19 09:36
Weekly Report: what happened at TBRIF last week (0105-0109)?
Weekly Report · 01/12 09:35
Weekly Report: what happened at TBRIF last week (1229-0102)?
Weekly Report · 01/05 09:33
Weekly Report: what happened at TBRIF last week (1222-1226)?
Weekly Report · 12/29/2025 09:32
Weekly Report: what happened at TBRIF last week (1215-1219)?
Weekly Report · 12/22/2025 09:32
Therma Bright Investee InStatin Pivots to COPD Lead Program and Advances Inhaled Statin Pipeline
TipRanks · 12/18/2025 13:23
Weekly Report: what happened at TBRIF last week (1208-1212)?
Weekly Report · 12/15/2025 09:35
Weekly Report: what happened at TBRIF last week (1201-1205)?
Weekly Report · 12/08/2025 09:35
Weekly Report: what happened at TBRIF last week (1124-1128)?
Weekly Report · 12/01/2025 09:33
Weekly Report: what happened at TBRIF last week (1117-1121)?
Weekly Report · 11/24/2025 09:35
Weekly Report: what happened at TBRIF last week (1110-1114)?
Weekly Report · 11/17/2025 09:36
More
Webull provides a variety of real-time TBRIF stock news. You can receive the latest news about Therma Bright Inc through multiple platforms. This information may help you make smarter investment decisions.
About TBRIF
Therma Bright Inc. is a Canada-based developer and investment partner specializing in advanced diagnostic and medical device technologies that address key healthcare challenges. The Company is developing, acquiring, manufacturing and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace focused on three key strategic areas: respiratory disease, vascular health and consumer medical devices. Its respiratory disease portfolio includes AI4LYF Digital Cough Technology and InStatin-novel inhaled treatment for asthma and COPD. Its vascular disease portfolio includes Inretio-ischemic stroke treatment and Venowave-Deep Vein Thrombosis Treatment Device (DVT). Its consumer health portfolio consists of AcuVid Covid-19 Rapid Antigen Saliva Test, Benepod-Contrast Therapy Device, TheroZAP-Thermal Therapy Device and InterceptCS-Cold Sore Prevention System. The Company holds trademarks for Therozap, InterceptCS and AcuVid.